\-\ Texto\\:\\ \ \(0\)\
\-\ t\\ 98\\ p\\ 115\\ bp\\ 122\\/88\\ respiratory\\ rate\\ 18\\ o2\\ \ \(0\)\
\-\ sat\\ 95\\%\\ on\\ room\\ air\ \(0\)\
\-\ ekg\\ sinus\\ tachy\\,\\ normal\\ axis\\.\ \(0\)\
\-\ pt\\/ptt\\ 35\\/37\ \(0\)\
\-\ inr\\ 3\\.5\ \(0\)\
\-\ ivc\\ fiter\\ \\(trapease\\)\\ placement\\.\\ \\ continuation\\ of\\ coumadin\\ \\(indenfinitely\\)\\ and\\ iv\\ heparin\\ for\\ 7\\ days\\.\ \(0\)\
\-\ right\\ and\\ left\\ lower\\ extremity\\ dvts\\ and\\ significant\\ thrombus\\ load\\ within\\ the\\ main\\,\\ lobar\\ and\\ segmental\\ branches\\ of\\ the\\ right\\ and\\ left\\ pulmonary\\ arteries\\.\ \(0\)\
\-\ pulmonary\\ embolism\ \(77\)\
\-\ causes\\ of\\ hypercoagulability\\.\ \(0\)\
\-\ protein\\ c\\,\\ protein\\ s\\,\\ anti\\-thrombin\\ iii\\ deficiency\\.\ \(0\)\
\-\ factor\\ v\\ leiden\\ mutation\\.\ \(0\)\
\-\ tumor\\,\\ trauma\\,\\ surgery\\,\\ immobility\\.\ \(0\)\
\-\ patient\\ with\\ recent\\ diagnosis\\ of\\ right\\ lower\\ extremity\\ dvt\\ 7\\ days\\ prior\\ to\\ presentation\\ to\\ the\\ er\\.\\ \\ chief\\ complaint\\ is\\ increased\\ swelling\\ in\\ the\\ right\\ lower\\ extremity\\,\\ shortness\\ of\\ breath\\,\\ and\\ chest\\ pain\\.\ \(0\)\
\-\ at\\ the\\ time\\ of\\ presentation\\ he\\ had\\ been\\ on\\ lovenox\\ \\(sq\\ low\\ molecular\\ weight\\ heparin\\)\\ and\\ coumadin\\ for\\ 7\\ days\\.\ \(0\)\
\-\ although\\ the\\ patient\\ was\\ not\\ considered\\ an\\ anitcoagulation\\ treatment\\ failure\\ \\(he\\ had\\ only\\ been\\ on\\ treatment\\ for\\ 7\\ days\\)\\,\\ the\\ thrombus\\ burden\\ within\\ the\\ pulmonary\\ arteries\\ and\\ the\\ size\\ of\\ the\\ bilateral\\ lower\\ extremity\\ thrombi\\ put\\ him\\ at\\ sigficant\\ risk\\ for\\ adverse\\ outcome\\ from\\ subsequent\\ pulmonary\\ embolism\\.\ \(0\)\
\-\ indications\\ for\\ ivc\\ catheters\\ include\\:\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ 7\\:\\ 0\\.059803742078686245\ \(0\)\
\-\ extremity\\:\\ 0\\.05708052912588927\ \(0\)\
\-\ coumadin\\:\\ 0\\.04944585426761956\ \(0\)\
\-\ heparin\\:\\ 0\\.04803808550207383\ \(0\)\
\-\ days\\:\\ 0\\.04783697344606351\ \(0\)\
\-\ pulmonary\\:\\ 0\\.04559909242411075\ \(0\)\
\-\ ivc\\:\\ 0\\.04157843421849482\ \(0\)\
\-\ 122\\/88\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ 35\\/37\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ fiter\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ trapease\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ indenfinitely\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ anti\\-thrombin\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ sigficant\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ protein\\:\\ 0\\.04004293721573684\ \(0\)\
\-\ thrombus\\:\\ 0\\.03941286533001126\ \(0\)\
\-\ embolism\\:\\ 0\\.038180725440519286\ \(0\)\
\-\ sq\\:\\ 0\\.03708845316623997\ \(0\)\
\-\ anitcoagulation\\:\\ 0\\.03708845316623997\ \(0\)\
\-\ tachy\\:\\ 0\\.035237014316430997\ \(0\)\
\-\ pt\\/ptt\\:\\ 0\\.035237014316430997\ \(0\)\
\-\ lower\\:\\ 0\\.03510250355002489\ \(0\)\
\-\ dvts\\:\\ 0\\.03392339754724478\ \(0\)\
\-\ immobility\\:\\ 0\\.03290447722160912\ \(0\)\
\-\ arteries\\:\\ 0\\.03230505721220074\ \(0\)\
\-\ leiden\\:\\ 0\\.03207195869743581\ \(0\)\
\-\ 115\\:\\ 0\\.03022051984762684\ \(0\)\
\-\ load\\:\\ 0\\.03022051984762684\ \(0\)\
\-\ hypercoagulability\\:\\ 0\\.03022051984762684\ \(0\)\
\-\ thrombi\\:\\ 0\\.03022051984762684\ \(0\)\
\-\ molecular\\:\\ 0\\.029739421602613936\ \(0\)\
\-\ continuation\\:\\ 0\\.029304215302137566\ \(0\)\
\-\ lovenox\\:\\ 0\\.028541411262579728\ \(0\)\
\-\ adverse\\:\\ 0\\.02820301869566776\ \(0\)\
\-\ burden\\:\\ 0\\.027887982752804966\ \(0\)\
\-\ catheters\\:\\ 0\\.027593286309254412\ \(0\)\
\-\ presentation\\:\\ 0\\.02688037109124276\ \(0\)\
\-\ put\\:\\ 0\\.02680858193972629\ \(0\)\
\-\ indications\\:\\ 0\\.025741847459445442\ \(0\)\
\-\ mutation\\:\\ 0\\.02487772873963481\ \(0\)\
\-\ dvt\\:\\ 0\\.024573201915439963\ \(0\)\
\-\ inr\\:\\ 0\\.024428230690259227\ \(0\)\
\-\ 98\\:\\ 0\\.024151405933106558\ \(0\)\
\-\ ekg\\:\\ 0\\.02352491679377558\ \(0\)\
\-\ outcome\\:\\ 0\\.02329655870895977\ \(0\)\
\-\ chief\\:\\ 0\\.02307907903320975\ \(0\)\
\-\ 3\\.5\\:\\ 0\\.02277112797934887\ \(0\)\
\-\ lobar\\:\\ 0\\.022482639844090737\ \(0\)\
\-\ o2\\:\\ 0\\.022390390038987906\ \(0\)\
\-\ sat\\:\\ 0\\.02221130002458936\ \(0\)\
\-\ 95\\:\\ 0\\.02195518373851154\ \(0\)\
\-\ he\\:\\ 0\\.02177340038386319\ \(0\)\
\-\ v\\:\\ 0\\.021408146296444778\ \(0\)\
\-\ him\\:\\ 0\\.021408146296444778\ \(0\)\
\-\ branches\\:\\ 0\\.021335085377054638\ \(0\)\
\-\ been\\:\\ 0\\.021231003556748777\ \(0\)\
\-\ deficiency\\:\\ 0\\.021053999107650833\ \(0\)\
\-\ axis\\:\\ 0\\.02078921710924741\ \(0\)\
\-\ segmental\\:\\ 0\\.02047847070173592\ \(0\)\
\-\ p\\:\\ 0\\.02002146860786842\ \(0\)\
\-\ factor\\:\\ 0\\.019914023414214565\ \(0\)\
\-\ c\\:\\ 0\\.018547617501644447\ \(0\)\
\-\ iii\\:\\ 0\\.018317339631202016\ \(0\)\
\-\ main\\:\\ 0\\.018170029758059453\ \(0\)\
\-\ t\\:\\ 0\\.018062584564405598\ \(0\)\
\-\ complaint\\:\\ 0\\.01802732407995852\ \(0\)\
\-\ bp\\:\\ 0\\.016938689269707385\ \(0\)\
\-\ 18\\:\\ 0\\.016938689269707385\ \(0\)\
\-\ had\\:\\ 0\\.01683881113461834\ \(0\)\
\-\ room\\:\\ 0\\.01677559300211798\ \(0\)\
\-\ for\\:\\ 0\\.016646304763532307\ \(0\)\
\-\ right\\:\\ 0\\.016468159070509893\ \(0\)\
\-\ shortness\\:\\ 0\\.01641626757483184\ \(0\)\
\-\ respiratory\\:\\ 0\\.016199361940197124\ \(0\)\
\-\ placement\\:\\ 0\\.015837492663237578\ \(0\)\
\-\ treatment\\:\\ 0\\.015795588672154217\ \(0\)\
\-\ considered\\:\\ 0\\.015751335200660486\ \(0\)\
\-\ failure\\:\\ 0\\.015285197638499391\ \(0\)\
\-\ rate\\:\\ 0\\.015208773929113437\ \(0\)\
\-\ causes\\:\\ 0\\.015189866200044802\ \(0\)\
\-\ subsequent\\:\\ 0\\.015189866200044802\ \(0\)\
\-\ er\\:\\ 0\\.014968877428986126\ \(0\)\
\-\ within\\:\\ 0\\.014887044825443667\ \(0\)\
\-\ breath\\:\\ 0\\.014589577891549535\ \(0\)\
\-\ sinus\\:\\ 0\\.014270132281472317\ \(0\)\
\-\ iv\\:\\ 0\\.014239383276078052\ \(0\)\
\-\ risk\\:\\ 0\\.014133363686571171\ \(0\)\
\-\ weight\\:\\ 0\\.013986053813428607\ \(0\)\
\-\ air\\:\\ 0\\.013202112450008976\ \(0\)\
\-\ \\(\\:\\ 0\\.013193821483906128\ \(0\)\
\-\ although\\:\\ 0\\.013177759272039286\ \(0\)\
\-\ recent\\:\\ 0\\.013117438579177155\ \(0\)\
\-\ size\\:\\ 0\\.013081624983464709\ \(0\)\
\-\ \\)\\:\\ 0\\.013032651910745298\ \(0\)\
\-\ swelling\\:\\ 0\\.01299913636521065\ \(0\)\
\-\ \\,\\:\\ 0\\.01236119020626883\ \(0\)\
\-\ only\\:\\ 0\\.01173247332641523\ \(0\)\
\-\ s\\:\\ 0\\.011190719941162497\ \(0\)\
\-\ time\\:\\ 0\\.011021010170042523\ \(0\)\
\-\ include\\:\\ 0\\.010945906338037839\ \(0\)\
\-\ low\\:\\ 0\\.010850082433179906\ \(0\)\
\-\ trauma\\:\\ 0\\.010671272976063602\ \(0\)\
\-\ at\\:\\ 0\\.010573179477914457\ \(0\)\
\-\ significant\\:\\ 0\\.010492452744539832\ \(0\)\
\-\ prior\\:\\ 0\\.010018779781745951\ \(0\)\
\-\ on\\:\\ 0\\.009916315237882577\ \(0\)\
\-\ increased\\:\\ 0\\.009545592610957332\ \(0\)\
\-\ surgery\\:\\ 0\\.009474881572421346\ \(0\)\
\-\ bilateral\\:\\ 0\\.00946948734846778\ \(0\)\
\-\ chest\\:\\ 0\\.009336662100719264\ \(0\)\
\-\ \\%\\:\\ 0\\.009101922526694098\ \(0\)\
\-\ tumor\\:\\ 0\\.009096951148907814\ \(0\)\
\-\ diagnosis\\:\\ 0\\.008959905620001917\ \(0\)\
\-\ left\\:\\ 0\\.008731554970528901\ \(0\)\
\-\ patient\\:\\ 0\\.007822757359967012\ \(0\)\
\-\ and\\:\\ 0\\.00657567144227282\ \(0\)\
\-\ the\\:\\ 0\\.006312752726192959\ \(0\)\
\-\ normal\\:\\ 0\\.006116951847484479\ \(0\)\
\-\ from\\:\\ 0\\.005782811475590011\ \(0\)\
\-\ not\\:\\ 0\\.005638441423479156\ \(0\)\
\-\ an\\:\\ 0\\.005395729973902876\ \(0\)\
\-\ \\:\\:\\ 0\\.005161072219135456\ \(0\)\
\-\ pain\\:\\ 0\\.004765334098313857\ \(0\)\
\-\ was\\:\\ 0\\.004512682749834186\ \(0\)\
\-\ to\\:\\ 0\\.00390016537390855\ \(0\)\
\-\ of\\:\\ 0\\.003723865778931137\ \(0\)\
\-\ is\\:\\ 0\\.002567537800843496\ \(0\)\
\-\ \\.\\:\\ 0\\.0019451800601285628\ \(0\)\
\-\ in\\:\\ 0\\.001924188265480616\ \(0\)\
\-\ with\\:\\ 0\\.0005342656442460719\ \(0\)\
